|
|||||
|
|
Potential impact of a delayed ADAMTS13 result in the treatment of thrombotic microangiopathy: an economic analysis |
|
| Authors: | Chong H. Kim Sierra C. Simmons Sarah F. Wattar Ameneh Azad Huy P. Pham |
| Affiliation: | 1. Department of Clinical Pharmacy, University of Colorado Anschutz Medical Campus, Aurora, CO, USA;2. Department of Pathology, Michigan Pathology Specialists, Spectrum Health Hospitals, Grand Rapids, MI, USA;3. Department of Pathology, Keck School of Medicine of the University of Southern California, Los Angeles, CA, USA |
| Abstract: | |
| Keywords: | ADAMTS13 assay evaluation financial impact thrombotic microangiopathy TTP |